Salmeterol

Common Uses

Salmeterol is primarily prescribed for the long-term control and prevention of symptoms associated with respiratory conditions. It works by relaxing the muscles in the airways to improve breathing.

Asthma Management

In patients with asthma, salmeterol is used as a maintenance treatment to prevent symptoms such as wheezing, shortness of breath, and chest tightness. It is generally used in combination with a long-term asthma control medication, such as an inhaled corticosteroid.

Chronic Obstructive Pulmonary Disease (COPD)

Salmeterol is used for the long-term maintenance treatment of airflow obstruction in people with COPD, including:

• Chronic bronchitis
• Emphysema

Exercise-Induced Bronchospasm

This medication is also used to prevent bronchospasm (narrowing of the airways) that is triggered by exercise. When used for this purpose, it is typically inhaled before physical activity to help keep the airways open.

Important Usage Information

Salmeterol is a maintenance medication and is not intended for the relief of sudden breathing problems. It should not be used as a rescue inhaler to treat an acute asthma attack or a sudden worsening of COPD symptoms.

Mechanism of Action

Salmeterol belongs to a group of medicines called long-acting beta-agonists (LABAs). It works by stimulating specific receptors known as beta2-adrenoceptors, which are found on the smooth muscle cells lining the airways.

When salmeterol binds to these receptors, it triggers the muscles around the bronchial tubes to relax. This process, called bronchodilation, widens the airways and allows more air to flow into and out of the lungs, making breathing easier.

Duration and Use

Unlike short-acting inhalers that work immediately, salmeterol is designed to provide long-lasting relief. Key aspects of its function include:

• Extended Duration: The effects of salmeterol typically last for at least 12 hours, providing consistent airway opening throughout the day or night.
• Slow Onset: It takes longer to begin working compared to rescue medications. Because of this, it is used for the daily maintenance and prevention of symptoms rather than for treating a sudden asthma attack or bronchospasm.
• Prevention: By keeping the muscles relaxed over time, it helps prevent symptoms such as wheezing, chest tightness, and shortness of breath associated with asthma and chronic obstructive pulmonary disease (COPD).

Common Side Effects

Many people using salmeterol do not experience significant side effects. When they do occur, common symptoms may include:

• Headache
• Dizziness or lightheadedness
• Nervousness or shaking (tremors)
• Difficulty falling asleep or staying asleep
• Throat irritation, cough, or hoarseness
• Stuffy or runny nose
• Muscle cramps
• Nausea, stomach pain, or diarrhea

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Chest pain
• Fast, pounding, or irregular heartbeat
• Severe headache or blurred vision
• Signs of an allergic reaction, such as rash, hives, or swelling of the face, lips, tongue, and throat
• Difficulty breathing or swallowing
• Sudden, severe wheezing or breathing problems immediately after using the medication
• Signs of low potassium levels, such as muscle weakness, leg cramps, or extreme thirst

Asthma-Related Death Warning

Salmeterol belongs to a class of medications called long-acting beta2-adrenergic agonists (LABAs). Data from clinical trials indicate that LABAs increase the risk of asthma-related death. For the treatment of asthma, salmeterol must only be used as an add-on therapy to an inhaled corticosteroid. It should not be used as the sole maintenance therapy for asthma.

Acute Episodes

This medication is intended for long-term maintenance and should not be started in patients with rapidly deteriorating or life-threatening episodes of asthma or COPD. It is not a rescue inhaler and will not work fast enough to treat a sudden asthma attack. A separate short-acting inhaler must be used for acute symptoms.

Paradoxical Bronchospasm

In some cases, inhaled salmeterol can cause paradoxical bronchospasm, a condition where the airways tighten and breathing worsens immediately after taking a dose. If this occurs, the medication should be discontinued immediately and alternative treatment sought.

Cardiovascular and Other Conditions

Salmeterol can produce significant cardiovascular effects, such as increased pulse rate, elevated blood pressure, and heart rhythm changes. Caution is advised for patients with:

• Pre-existing heart disease or hypertension.
• Seizure disorders.
• Thyrotoxicosis (overactive thyroid).
• Diabetes, due to potential increases in blood glucose.
• Hypokalemia (low blood potassium levels).

Contraindications

Salmeterol is contraindicated in patients with a history of hypersensitivity to the drug or its components. Some formulations contain lactose and are contraindicated for patients with a severe hypersensitivity to milk proteins.

Pregnancy

There is limited information regarding the safety of salmeterol use during pregnancy. Adequate and well-controlled studies in humans have not been conducted to determine if the medication causes birth defects or other developmental issues. Like other medications in its class (beta-agonists), salmeterol may interfere with uterine contractions during labor and delivery.

Healthcare providers typically only prescribe salmeterol to pregnant individuals if the potential benefit to the parent outweighs the potential risk to the fetus. If you are pregnant or planning to become pregnant, discuss the risks and benefits of continuing this medication with your doctor.

Breastfeeding

It is currently unknown whether salmeterol passes into human breast milk. Because many medications can be excreted in milk, caution is recommended when using salmeterol while breastfeeding. You should consult with your healthcare provider to determine the best course of action for your specific situation, considering both the benefits of breastfeeding and the clinical need for the medication.

Dosage Forms

Salmeterol is primarily available as an inhalation powder. This form is used with a dry powder inhaler (DPI) device that delivers the medication to the lungs when you breathe in through the mouthpiece.

• Inhalation Powder: The medication is typically contained in individual foil-wrapped blisters within a plastic inhaler device. Each blister holds a single, pre-measured dose of the dry powder.

Strengths

The single-ingredient inhalation powder is commonly available in a strength of 50 micrograms (mcg) per inhalation.

Salmeterol is also frequently available in combination with other medications, such as the corticosteroid fluticasone. These combination products may be available in the following formats:

• Inhalation Powder: Dry powder inhalers containing various concentrations of both medications.
• Inhalation Aerosol: Metered-dose inhalers (MDI) that use a pressurized canister to deliver a spray of the combined medications.

FDA Approval and Indications

Salmeterol was first approved by the U.S. Food and Drug Administration (FDA) in 1994. It is indicated for the long-term, twice-daily treatment of asthma and for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is also approved for the prevention of exercise-induced bronchospasm (EIB) in patients aged 4 years and older.

Boxed Warning and Safety Updates

Salmeterol carries a Boxed Warning regarding an increased risk of asthma-related death when used as monotherapy (alone). In 2017, the FDA reviewed large safety clinical trials and determined that long-acting beta-agonists (LABAs) do not significantly increase the risk of serious asthma-related events when used in combination with inhaled corticosteroids (ICS). Consequently, the Boxed Warning was removed from the labeling of products that combine a LABA with an ICS, but it remains on stand-alone salmeterol products.

Regulatory Requirements for Use

Due to safety considerations, the FDA maintains specific requirements for the use of salmeterol:

• Asthma Treatment: Salmeterol should never be used alone to treat asthma. It must always be used in combination with an inhaled corticosteroid. If asthma is well-controlled, healthcare providers are encouraged to evaluate if the patient can maintain control on an ICS alone.
• COPD Treatment: For patients with COPD, salmeterol can be used as a stand-alone maintenance therapy, as the safety concerns regarding asthma-related death have not been found to apply to the COPD population.
• Acute Symptoms: Salmeterol is not FDA-approved for the treatment of acute, or "rescue," symptoms of asthma or COPD. A separate short-acting inhaler is required for sudden breathing problems.

Long-Term Control

Salmeterol is a long-acting medication used to help control asthma symptoms over time. It is typically prescribed for patients whose asthma is not well-managed by a steroid inhaler alone. It works by relaxing the muscles in the airways to keep them open for at least 12 hours.

Safety and Combination Therapy

When used for asthma, salmeterol must always be used with an inhaled corticosteroid. Using this type of medication alone for asthma can increase the risk of severe breathing problems and asthma-related death. Many people use a single inhaler that contains both salmeterol and a steroid medication.

Limitations of Use

• Not for sudden attacks: Salmeterol is not a rescue medicine. It will not stop an asthma attack that has already started. A fast-acting rescue inhaler must be used for sudden symptoms.
• Dosing: It is usually used twice a day, about 12 hours apart. Do not use more than the prescribed amount, even if you do not feel better right away.

Exercise-Induced Asthma

Salmeterol can be used to prevent breathing problems triggered by exercise. It should be taken at least 30 to 60 minutes before physical activity. However, if you already use salmeterol twice a day for your asthma, you should not take an extra dose before exercising.